Semaglutide
Acts on a system called GLP-1, which helps control appetite and blood sugar.
Explore Semaglutide →
← All research topics
METABOLISM, APPETITE & BODY FAT
Understand what researchers are studying—and how the compounds differ.
Metabolism is how your body turns food into energy. It also includes how your body uses and stores that energy.
This page explains research about hunger, blood sugar, body fat, and muscle in plain English.
THE BASICS
What does “metabolic health” mean?
It describes how well your body handles energy. Blood sugar is one part of that picture.
What does “body composition” mean?
It means what your body is made of, including fat, muscle, bone, and water.
Losing weight and losing fat are different. A lower number on the scale can come from changes in fat, muscle, or water.
How do hormones fit in?
Hormones carry messages through your body. Some help control hunger, fullness, and blood sugar.
Researchers study compounds that act on the systems receiving those messages.
HOW ARE THESE COMPOUNDS DIFFERENT?
Your body has several systems that help manage hunger and energy. These compounds act on different parts of those systems.
Tirzepatide
Acts on two systems: GIP and GLP-1. Both are involved in how the body responds to food.
Explore Tirzepatide →Retatrutide
Acts on three systems: GIP, GLP-1, and glucagon. Researchers study how this combination affects appetite, blood sugar, and energy use.
Explore Retatrutide →Cagrilintide
Works differently. It mimics a hormone called amylin, which helps signal fullness after eating.
Explore Cagrilintide →Does acting on more systems mean a compound is better?
No. The number of systems involved does not tell you which compound is safer or which will produce better results. Those questions require studies.
WHAT ABOUT MOTS-C AND TESAMORELIN?
These are separate areas of research. They work differently from the compounds above.
Explore their individual pages to understand what researchers are studying.
HOW TO UNDERSTAND A STUDY
Before trusting a claim, check these four things:
1. Who was studied?
Was the research done in cells, animals, or people? Results from one group do not automatically apply to another.
2. What changed?
Did researchers measure hunger, blood sugar, body weight, body fat, or muscle? These are different results.
3. How long did the study last?
A short study cannot tell us everything about long-term results or safety.
4. What problems were reported?
Look for side effects, people who stopped the study, and questions the study could not answer.
A published study also does not prove the contents, purity, or quality of a product sold by a supplier.
READ THE STUDIES
These links are starting points for learning more:
- Semaglutide: STEP 1 study, published in 2021. →
- Tirzepatide: SURMOUNT-1 study, published in 2022. →
- Retatrutide: Phase 2 study, published in 2023. →
- Cagrilintide: Phase 2 study, published in 2021. →
These studies tested the compounds separately. Comparing their results does not give us a fair winner because the participants and study designs differed.
WANT MORE DETAIL?
READ THE FULL METABOLIC RESEARCH GUIDE
Explore longer explanations and more information about the compounds discussed on this page.
For research education only. This page does not provide instructions for personal use or dosing.
05 / GO DEEPER
THE METABOLIC DOSSIER
Keep exploring in the original book. Prefer a larger view? Open the book directly →
Explore another research topic → · Search all compound profiles →
METABOLIC HEALTH & BODY COMPOSITION
RELATED RESEARCH PRODUCTS
Explore compounds associated with metabolic signaling, appetite pathways, energy regulation and body-composition research.
